Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,551 JPY | +2.43% | +0.51% | +17.54% |
Apr. 10 | Roche’s HER2-Low Metastatic Breast Cancer Diagnostic Test Secures CE Mark | MT |
Apr. 08 | AstraZeneca's Enhertu Receives FDA Approval for HER2-Positive Solid Tumor Indication | MT |
- Stock Market
- Equities
- 4568 Stock
- News Daiichi Sankyo Co., Ltd.